Red Maple LifeSciences

Science

  1. Foundational Research

    EnzyLock is built on over $2M of foundational biomaterial research conducted in the laboratory of Prof. Anita Shukla at Brown University, one of the leading academic groups in the world working on stimuli-responsive hydrogels and infection-targeted biomaterials.

  2. Patent Portfolio

    Red Maple LifeSciences holds an exclusive option to license issued patents covering its bacteria-responsive wound dressing technology. Legal counsel for the licensing agreement is Orrick, Herrington and Sutcliffe LLP.

  3. Preclinical data

    EnzyLock has demonstrated efficacy in preclinical wound infection models, showing complete infection clearance and improved tissue healing compared to standard of care dressings.

  4. Publications

    The technology has been validated in peer-reviewed research and is protected by issued patents.